Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Severe neonatal spondylometaphyseal dysplasia in two siblings.
Czarny-Ratajczak M, Chrzanowska K, Bieganski T, Sulko J, Baranska D, Kocyla-Karczmarewicz B, Kuszel L, Jakubowski L, Niedzielski K, Kozlowski K.
Am J Med Genet A. 2009 Oct;149A(10):2166-72. doi: 10.1002/ajmg.a.33016.
Related citations
COL2A1-related skeletal dysplasias with predominant metaphyseal involvement.
Walter K, Tansek M, Tobias ES, Ikegawa S, Coucke P, Hyland J, Mortier G, Iwaya T, Nishimura G, Superti-Furga A, Unger S.
Am J Med Genet A. 2007 Jan 15;143(2):161-7.
Orthopaedic manifestations and management of spondyloepimetaphyseal dysplasia Strudwick type.
Amirfeyz R, Taylor A, Smithson SF, Gargan MF.
J Pediatr Orthop B. 2006 Jan;15(1):41-4.
MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMD(MO).
Kennedy AM, Inada M, Krane SM, Christie PT, Harding B, López-Otín C, Sánchez LM, Pannett AA, Dearlove A, Hartley C, Byrne MH, Reed AA, Nesbit MA, Whyte MP, Thakker RV.
J Clin Invest. 2005 Oct;115(10):2832-42.
A glycine to aspartic acid substitution of COL2A1 in a family with the Strudwick variant of spondyloepimetaphyseal dysplasia.
Tysoe C, Saunders J, White L, Hills N, Nicol M, Evans G, Cole T, Chapman S, Pope FM.
QJM. 2003 Sep;96(9):663-71.
Linkage studies of a Missouri kindred with autosomal dominant spondyloepimetaphyseal dysplasia (SEMD) indicate genetic heterogeneity.
Gertner JM, Whyte MP, Dixon PH, Pang JT, Trump D, Pearce SH, Wooding C, Thakker RV.
J Bone Miner Res. 1997 Aug;12(8):1204-9.
Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type.
Tiller GE, Polumbo PA, Weis MA, Bogaert R, Lachman RS, Cohn DH, Rimoin DL, Eyre DR.
Nat Genet. 1995 Sep;11(1):87-9.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on